Ann Dermatol.  2020 Apr;32(2):172-174. 10.5021/ad.2020.32.2.172.

Psoriasiform Dermatitis Related with T-Cell Immunoreceptor with Immunoglobulin and Immunoreceptor Tyrosine-Based Inhibitory Motif Domains Inhibitor in a Patient with Non-Small-Cell Lung Cancer

• Choi Y
• Jang D
• Byun HJ
• Oh SJ
• Kim CR
• Park JH
• Lee JH
• Lee DY

• KMID: 2471348
• DOI: http://doi.org/10.5021/ad.2020.32.2.172

Abstract

No abstract available.

MeSH Terms

Dermatitis*
Humans
Immunoglobulins*
Lung Neoplasms*
Lung*
T-Lymphocytes*
Immunoglobulins

Figure

• 

  Fig. 1 (A) Timeline of chemotherapy. (B) Erythematous plaques and papules during pembrolizumab treatment. (C) Normal nail plate during pembrolizumab treatment. (D, E) Hyperkeratotic scaly erythematous plaques during T-cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domains (TIGIT) inhibitor treatment. (F) Nail dystrophy during TIGIT inhibitor treatment. We received the patient's consent form about publishing all photographic materials.

• 

  Fig. 2 Histopathological images of skin biopsy specimen of the leg. (A) Acanthosis with elongated rete ridges on epidermis and papillary dermal inflammatory infiltrations (H&E, ×100). (B) Parakeratosis and microabscess in stratum corneum (H&E, ×400).

Reference

1. Hong J, Bernstein D. A review of drugs that induce or exacerbate psoriasis. J Psoriasis Psoriatic Arthritis. 2012; 18:2–11.

2. Kurtulus S, Sakuishi K, Zhang H, Joller N, Tan D, Smyth M, et al. Mechanisms of TIGIT-driven immune suppression in cancer. J Immunother Cancer. 2014; 2:Suppl 3. O13.

3. Dixon KO, Schorer M, Nevin J, Etminan Y, Amoozgar Z, Kondo T, et al. Functional Anti-TIGIT antibodies regulate development of autoimmunity and antitumor immunity. J Immunol. 2018; 200:3000–3007.

4. Voudouri D, Nikolaou V, Laschos K, Charpidou A, Soupos N, Triantafyllopoulou I, et al. Anti-PD1/PDL1 induced psoriasis. Curr Probl Cancer. 2017; 41:407–412.

5. Wang FF, Wang Y, Wang L, Wang TS, Bai YP. TIGIT expression levels on CD4+ T cells are correlated with disease severity in patients with psoriasis. Clin Exp Dermatol. 2018; 43:675–682.